Support and Resistance Levels
Past performance
About Accretion Pharmaceuticals Ltd Accretion Pharmaceuticals, incorporated in 2012, specializes in the manufacturing and marketing of diverse pharmaceutical products, including tablets, capsules, oral liquids, external preparations (such as ointments, creams, gels, and lotions), medicated shampoos, mouthwash, dusting powder, and oral powders. Initially established as a partnership firm, it transitioned into a limited company named Accretion Pharmaceuticals Limited in November 2023. Its manufacturing operations commenced in 2014 at its facility in Sanand, Ahmedabad, Gujarat.
The company caters to various pharmaceutical needs through direct sales, loan licensing, and contract manufacturing. Accretion Pharmaceuticals holds multiple ISO certifications, including ISO 9001:2015, ISO 14001:2015, and ISO 22000:2018, ensuring adherence to quality management, environmental standards, and food safety systems. Its experienced board of directors and management team bring extensive industry expertise, which contributes to its credibility and operational efficiency.
To expand its operations and fuel growth, Accretion Pharmaceuticals plans an Initial Public Offering (IPO) with 30,00,000 fresh equity shares. This move strategically positions the company for scaling its manufacturing capabilities and reaching a broader market. The IPO aligns with the company’s vision of leveraging market opportunities in the pharmaceutical sector, which continues to display strong demand dynamics globally.
With established manufacturing infrastructure, regulatory certifications, and a professional leadership team, Accretion Pharmaceuticals represents a growing player in the pharmaceutical sector, emphasizing quality healthcare solutions and sustainable business practices.